Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	small GTPase binding	IPO8 MYO5B DOCK11 ARHGAP44 TSC2 ANKRD27 STRIP1	1.71e-04	321	73	7	GO:0031267
GeneOntologyMolecularFunction	GTPase binding	IPO8 MYO5B DOCK11 ARHGAP44 TSC2 ANKRD27 STRIP1	3.43e-04	360	73	7	GO:0051020
GeneOntologyMolecularFunction	ubiquitin protein ligase activity	CUL1 RNF123 UBE4B HECW2 WWP1 CBLC HERC3	4.17e-04	372	73	7	GO:0061630
GeneOntologyMolecularFunction	ubiquitin-like protein ligase activity	CUL1 RNF123 UBE4B HECW2 WWP1 CBLC HERC3	6.23e-04	398	73	7	GO:0061659
GeneOntologyBiologicalProcess	dendritic spine development	MYO5B ARHGAP44 CAPRIN2 EIF4G2 TSC2 SDK1 OPA1	5.55e-07	141	71	7	GO:0060996
GeneOntologyBiologicalProcess	dendrite development	MYO5B HECW2 ARHGAP44 CAPRIN2 EIF4G2 TSC2 SDK1 ANKRD27 OPA1	2.17e-06	335	71	9	GO:0016358
GeneOntologyBiologicalProcess	regulation of organelle organization	SPTBN5 OMA1 MYO3A RNH1 VILL HECW2 SPTA1 ARHGAP44 CAPN2 SMARCC1 TSC2 ARHGAP18 DNAI3 ARMH3 ANKRD27 OPA1 KLHL22	2.18e-06	1342	71	17	GO:0033043
GeneOntologyBiologicalProcess	regulation of cell morphogenesis	MYO5B SPTA1 CAPRIN2 ARHGAP18 ANKRD27 OPA1 STRIP2 STRIP1	9.20e-06	302	71	8	GO:0022604
GeneOntologyBiologicalProcess	negative regulation of organelle organization	SPTBN5 OMA1 VILL SPTA1 TSC2 DNAI3 ANKRD27 OPA1 KLHL22	1.37e-05	421	71	9	GO:0010639
GeneOntologyBiologicalProcess	regulation of dendritic spine development	CAPRIN2 EIF4G2 TSC2 SDK1 OPA1	1.55e-05	91	71	5	GO:0060998
GeneOntologyBiologicalProcess	regulation of anatomical structure morphogenesis	OMA1 RNH1 MYO5B HECW2 SPTA1 ARHGAP44 CAPRIN2 EIF4G2 TSC2 ARHGAP18 ANKRD27 OPA1 STRIP2 STRIP1	1.74e-05	1090	71	14	GO:0022603
GeneOntologyBiologicalProcess	regulation of dendrite morphogenesis	MYO5B HECW2 CAPRIN2 ANKRD27 OPA1	2.82e-05	103	71	5	GO:0048814
GeneOntologyBiologicalProcess	cell morphogenesis	MYO3A MYO5B HECW2 SPTA1 ARHGAP44 CAPRIN2 EIF4G2 TSC2 DMD ARHGAP18 ANKRD27 OPA1 STRIP2 STRIP1	4.75e-05	1194	71	14	GO:0000902
GeneOntologyBiologicalProcess	positive regulation of cell projection organization	MYO3A MYO5B DOCK11 CAPRIN2 EIF4G2 TSC2 DMD ANKRD27 OPA1	4.81e-05	494	71	9	GO:0031346
GeneOntologyBiologicalProcess	regulation of actin cytoskeleton organization	SPTBN5 MYO3A RNH1 VILL SPTA1 ARHGAP44 ARHGAP18 DNAI3	5.13e-05	384	71	8	GO:0032956
GeneOntologyBiologicalProcess	dendrite morphogenesis	MYO5B HECW2 ARHGAP44 CAPRIN2 ANKRD27 OPA1	6.19e-05	198	71	6	GO:0048813
GeneOntologyBiologicalProcess	positive regulation of dendrite morphogenesis	MYO5B CAPRIN2 ANKRD27 OPA1	8.39e-05	67	71	4	GO:0050775
GeneOntologyBiologicalProcess	actin cytoskeleton organization	SPTBN5 CATIP MYO3A RNH1 MYO5B VILL SPTA1 ARHGAP44 ARHGAP18 DNAI3 STRIP1	8.82e-05	803	71	11	GO:0030036
GeneOntologyBiologicalProcess	positive regulation of cell morphogenesis	MYO5B CAPRIN2 ANKRD27 OPA1	9.41e-05	69	71	4	GO:0010770
GeneOntologyBiologicalProcess	proteolysis involved in protein catabolic process	CUL1 OMA1 RNF123 UBE4B HECW2 WWP1 CAPN2 SMARCC1 CBLC HERC3 KLHL22	9.73e-05	812	71	11	GO:0051603
GeneOntologyBiologicalProcess	protein catabolic process	CUL1 OMA1 RNF123 AMER1 UBE4B HECW2 WWP1 CAPN2 SMARCC1 CBLC HERC3 MMP14 KLHL22	9.76e-05	1115	71	13	GO:0030163
GeneOntologyBiologicalProcess	positive regulation of dendritic spine development	CAPRIN2 EIF4G2 TSC2 OPA1	9.96e-05	70	71	4	GO:0060999
GeneOntologyBiologicalProcess	regulation of cellular component size	SPTBN5 MYO3A MYO5B VILL SPTA1 EIF4G2 TSC2 ARHGAP18	1.06e-04	426	71	8	GO:0032535
GeneOntologyBiologicalProcess	regulation of actin filament-based process	SPTBN5 MYO3A RNH1 VILL SPTA1 ARHGAP44 ARHGAP18 DNAI3	1.28e-04	438	71	8	GO:0032970
GeneOntologyBiologicalProcess	regulation of plasma membrane bounded cell projection organization	MYO3A MYO5B DOCK11 HECW2 ARHGAP44 CAPRIN2 EIF4G2 TSC2 DMD ANKRD27 OPA1	1.40e-04	846	71	11	GO:0120035
GeneOntologyBiologicalProcess	regulation of cytoskeleton organization	SPTBN5 MYO3A RNH1 VILL SPTA1 ARHGAP44 CAPN2 ARHGAP18 DNAI3	1.61e-04	579	71	9	GO:0051493
GeneOntologyBiologicalProcess	regulation of cell projection organization	MYO3A MYO5B DOCK11 HECW2 ARHGAP44 CAPRIN2 EIF4G2 TSC2 DMD ANKRD27 OPA1	1.66e-04	863	71	11	GO:0031344
GeneOntologyBiologicalProcess	negative regulation of cellular component organization	SPTBN5 OMA1 VILL SPTA1 ARHGAP44 TSC2 MMP14 DNAI3 ANKRD27 OPA1 KLHL22	1.68e-04	864	71	11	GO:0051129
GeneOntologyBiologicalProcess	regulation of dendrite development	MYO5B HECW2 CAPRIN2 ANKRD27 OPA1	1.68e-04	150	71	5	GO:0050773
GeneOntologyBiologicalProcess	dendritic spine morphogenesis	MYO5B ARHGAP44 CAPRIN2 OPA1	1.76e-04	81	71	4	GO:0060997
GeneOntologyBiologicalProcess	regulation of neuron projection development	MYO5B HECW2 ARHGAP44 CAPRIN2 EIF4G2 TSC2 DMD ANKRD27 OPA1	2.43e-04	612	71	9	GO:0010975
GeneOntologyBiologicalProcess	actin filament-based process	SPTBN5 CATIP MYO3A RNH1 MYO5B VILL SPTA1 ARHGAP44 ARHGAP18 DNAI3 STRIP1	2.68e-04	912	71	11	GO:0030029
GeneOntologyBiologicalProcess	ubiquitin-dependent protein catabolic process	CUL1 RNF123 UBE4B HECW2 WWP1 SMARCC1 CBLC HERC3 KLHL22	3.38e-04	640	71	9	GO:0006511
GeneOntologyBiologicalProcess	actin filament organization	SPTBN5 CATIP RNH1 MYO5B VILL SPTA1 ARHGAP18 DNAI3	3.54e-04	509	71	8	GO:0007015
GeneOntologyBiologicalProcess	modification-dependent protein catabolic process	CUL1 RNF123 UBE4B HECW2 WWP1 SMARCC1 CBLC HERC3 KLHL22	3.82e-04	651	71	9	GO:0019941
GeneOntologyBiologicalProcess	regulation of actin filament length	SPTBN5 MYO3A VILL SPTA1 ARHGAP18	3.91e-04	180	71	5	GO:0030832
GeneOntologyBiologicalProcess	modification-dependent macromolecule catabolic process	CUL1 RNF123 UBE4B HECW2 WWP1 SMARCC1 CBLC HERC3 KLHL22	4.04e-04	656	71	9	GO:0043632
GeneOntologyBiologicalProcess	actin filament polymerization	SPTBN5 CATIP VILL SPTA1 ARHGAP18	5.01e-04	190	71	5	GO:0030041
GeneOntologyBiologicalProcess	actin filament capping	SPTBN5 VILL SPTA1	5.34e-04	46	71	3	GO:0051693
GeneOntologyBiologicalProcess	regulation of actin filament organization	SPTBN5 RNH1 VILL SPTA1 ARHGAP18 DNAI3	5.84e-04	300	71	6	GO:0110053
GeneOntologyBiologicalProcess	dendritic spine organization	MYO5B ARHGAP44 CAPRIN2 OPA1	6.68e-04	115	71	4	GO:0097061
GeneOntologyBiologicalProcess	neurotransmitter receptor transport, endosome to plasma membrane	MYO5B ARHGAP44	7.54e-04	12	71	2	GO:0099639
GeneOntologyBiologicalProcess	negative regulation of actin filament depolymerization	SPTBN5 VILL SPTA1	7.65e-04	52	71	3	GO:0030835
GeneOntologyBiologicalProcess	protein monoubiquitination	CUL1 UBE4B KLHL22	8.55e-04	54	71	3	GO:0006513
GeneOntologyBiologicalProcess	hippo signaling	MOB1B MOB1A STRIP1	9.02e-04	55	71	3	GO:0035329
GeneOntologyBiologicalProcess	neuron projection organization	MYO5B ARHGAP44 CAPRIN2 OPA1	9.68e-04	127	71	4	GO:0106027
GeneOntologyBiologicalProcess	regulation of sodium ion transmembrane transporter activity	HECW2 DMD UTRN	1.00e-03	57	71	3	GO:2000649
GeneOntologyBiologicalProcess	regulation of filopodium assembly	MYO3A DOCK11 ARHGAP44	1.00e-03	57	71	3	GO:0051489
GeneOntologyBiologicalProcess	actin polymerization or depolymerization	SPTBN5 CATIP VILL SPTA1 ARHGAP18	1.01e-03	222	71	5	GO:0008154
GeneOntologyBiologicalProcess	cell morphogenesis involved in neuron differentiation	MYO3A MYO5B HECW2 ARHGAP44 CAPRIN2 EIF4G2 TSC2 ANKRD27 OPA1	1.03e-03	748	71	9	GO:0048667
GeneOntologyBiologicalProcess	positive regulation of T-helper 17 cell differentiation	OPA1 NLRP3	1.04e-03	14	71	2	GO:2000321
GeneOntologyBiologicalProcess	positive regulation of cell development	MYO5B CAPRIN2 EIF4G2 SMARCC1 MMP14 ANKRD27 OPA1 NLRP3	1.20e-03	614	71	8	GO:0010720
GeneOntologyBiologicalProcess	regulation of actin filament depolymerization	SPTBN5 VILL SPTA1	1.22e-03	61	71	3	GO:0030834
GeneOntologyBiologicalProcess	regulation of anatomical structure size	SPTBN5 MYO3A MYO5B VILL SPTA1 EIF4G2 TSC2 ARHGAP18	1.26e-03	618	71	8	GO:0090066
GeneOntologyBiologicalProcess	neuron projection development	MYO3A MYO5B UBE4B HECW2 ARHGAP44 CAPRIN2 EIF4G2 TSC2 DMD SDK1 ANKRD27 OPA1	1.36e-03	1285	71	12	GO:0031175
GeneOntologyBiologicalProcess	regulation of dendritic spine morphogenesis	ARHGAP44 CAPRIN2 OPA1	1.40e-03	64	71	3	GO:0061001
GeneOntologyBiologicalProcess	actin filament depolymerization	SPTBN5 VILL SPTA1	1.53e-03	66	71	3	GO:0030042
GeneOntologyBiologicalProcess	regulation of mitochondrial fusion	OMA1 OPA1	1.54e-03	17	71	2	GO:0010635
Domain	Spectrin	SPTBN5 SPTA1 DMD UTRN	1.70e-06	23	72	4	PF00435
Domain	Spectrin_repeat	SPTBN5 SPTA1 DMD UTRN	4.48e-06	29	72	4	IPR002017
Domain	Spectrin/alpha-actinin	SPTBN5 SPTA1 DMD UTRN	6.73e-06	32	72	4	IPR018159
Domain	SPEC	SPTBN5 SPTA1 DMD UTRN	6.73e-06	32	72	4	SM00150
Domain	DUF3402	STRIP2 STRIP1	1.47e-05	2	72	2	PF11882
Domain	N1221	STRIP2 STRIP1	1.47e-05	2	72	2	PF07923
Domain	Dystrophin	DMD UTRN	1.47e-05	2	72	2	IPR016344
Domain	DUF3402	STRIP2 STRIP1	1.47e-05	2	72	2	IPR021819
Domain	DUF3402	STRIP2 STRIP1	1.47e-05	2	72	2	SM01293
Domain	N1221	STRIP2 STRIP1	1.47e-05	2	72	2	SM01292
Domain	N1221	STRIP2 STRIP1	1.47e-05	2	72	2	IPR012486
Domain	WW	HECW2 WWP1 DMD UTRN	3.19e-05	47	72	4	PF00397
Domain	WW	HECW2 WWP1 DMD UTRN	3.47e-05	48	72	4	SM00456
Domain	WTX	AMER2 AMER1	4.39e-05	3	72	2	PF09422
Domain	Uncharacterised_FAM123	AMER2 AMER1	4.39e-05	3	72	2	IPR019003
Domain	WW_DOMAIN_2	HECW2 WWP1 DMD UTRN	4.42e-05	51	72	4	PS50020
Domain	WW_DOMAIN_1	HECW2 WWP1 DMD UTRN	4.42e-05	51	72	4	PS01159
Domain	WW_dom	HECW2 WWP1 DMD UTRN	4.78e-05	52	72	4	IPR001202
Domain	Actinin_actin-bd_CS	SPTBN5 DMD UTRN	9.20e-05	23	72	3	IPR001589
Domain	ACTININ_2	SPTBN5 DMD UTRN	9.20e-05	23	72	3	PS00020
Domain	ACTININ_1	SPTBN5 DMD UTRN	9.20e-05	23	72	3	PS00019
Domain	HECT	HECW2 WWP1 HERC3	1.50e-04	27	72	3	PF00632
Domain	HECTc	HECW2 WWP1 HERC3	1.50e-04	27	72	3	SM00119
Domain	HECT_dom	HECW2 WWP1 HERC3	1.50e-04	27	72	3	IPR000569
Domain	HECT	HECW2 WWP1 HERC3	1.50e-04	27	72	3	PS50237
Domain	EF-hand_dom_typ1	DMD UTRN	2.18e-04	6	72	2	IPR015153
Domain	EF-hand_dom_typ2	DMD UTRN	2.18e-04	6	72	2	IPR015154
Domain	EF-hand_2	DMD UTRN	2.18e-04	6	72	2	PF09068
Domain	EF-hand_3	DMD UTRN	2.18e-04	6	72	2	PF09069
Domain	Mob1_phocein	MOB1B MOB1A	3.04e-04	7	72	2	PF03637
Domain	MOB_kinase_act_fam	MOB1B MOB1A	3.04e-04	7	72	2	IPR005301
Domain	-	MOB1B MOB1A	3.04e-04	7	72	2	1.20.140.30
Domain	Mob1_phocein	MOB1B MOB1A	3.04e-04	7	72	2	SM01388
Domain	CENP-B_N	TIGD2 JRKL	6.46e-04	10	72	2	PF04218
Domain	CENPB	TIGD2 JRKL	9.43e-04	12	72	2	SM00674
Domain	HTH_Psq	TIGD2 JRKL	9.43e-04	12	72	2	IPR007889
Domain	DDE_1	TIGD2 JRKL	9.43e-04	12	72	2	PF03184
Domain	HTH_PSQ	TIGD2 JRKL	9.43e-04	12	72	2	PS50960
Domain	DDE_SF_endonuclease_dom	TIGD2 JRKL	9.43e-04	12	72	2	IPR004875
Domain	HTH_CENPB	TIGD2 JRKL	1.11e-03	13	72	2	PS51253
Domain	HTH_Tnp_Tc5	TIGD2 JRKL	1.11e-03	13	72	2	PF03221
Domain	HTH_CenpB_DNA-bd_dom	TIGD2 JRKL	1.11e-03	13	72	2	IPR006600
Domain	CH	SPTBN5 DMD UTRN	2.02e-03	65	72	3	SM00033
Domain	ZZ	DMD UTRN	2.15e-03	18	72	2	PF00569
Domain	ZF_ZZ_2	DMD UTRN	2.15e-03	18	72	2	PS50135
Domain	ZF_ZZ_1	DMD UTRN	2.15e-03	18	72	2	PS01357
Domain	Znf_ZZ	DMD UTRN	2.40e-03	19	72	2	IPR000433
Domain	ZnF_ZZ	DMD UTRN	2.40e-03	19	72	2	SM00291
Domain	CH	SPTBN5 DMD UTRN	2.50e-03	70	72	3	PF00307
Domain	-	SPTBN5 DMD UTRN	2.60e-03	71	72	3	1.10.418.10
Domain	MAGE_N	MAGEA1 MAGEB4	2.66e-03	20	72	2	SM01392
Domain	CH	SPTBN5 DMD UTRN	2.82e-03	73	72	3	PS50021
Domain	CH-domain	SPTBN5 DMD UTRN	3.04e-03	75	72	3	IPR001715
Domain	MAGE_N	MAGEA1 MAGEB4	3.22e-03	22	72	2	PF12440
Domain	MAGE_N	MAGEA1 MAGEB4	3.22e-03	22	72	2	IPR021072
Domain	-	SPTA1 CAPN2 CBLC DMD UTRN	3.35e-03	261	72	5	1.10.238.10
Domain	EF-hand-dom_pair	SPTA1 CAPN2 CBLC DMD UTRN	5.00e-03	287	72	5	IPR011992
Domain	P-loop_NTPase	MYO3A MYO5B ABCA13 ABCB5 MCM5 CARD10 OPA1 NLRP3 DDX1	5.15e-03	848	72	9	IPR027417
Domain	ZINC_PROTEASE	LVRN OMA1 MMP14	6.43e-03	98	72	3	PS00142
Domain	MAGE	MAGEA1 MAGEB4	7.59e-03	34	72	2	SM01373
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	MAGEA1 CUL1 RNH1 UBE4B POLR2B MCM3AP CAPN2 EIF4G2 SMARCC1 MCM5 MMP14 UTRN ANKRD27 DDX1	7.34e-07	1353	73	14	29467282
Pubmed	HERC5/IFI16/p53 signaling mediates breast cancer cell proliferation and migration.	CUL1 RNF123 UBE4B HECW2 WWP1	1.36e-06	90	73	5	35671810
Pubmed	Mapping the MOB proteins' proximity network reveals a unique interaction between human MOB3C and the RNase P complex.	DOCK11 MOB1B POLR2B EIF4G2 MOB1A SMARCC1 MCM5 DDX1	1.96e-06	399	73	8	37536630
Pubmed	Functional proteomics mapping of a human signaling pathway.	RNF123 MTF2 WWP1 MCM3AP EIF4G2 BCAT1 UTRN SDK1 ANKRD27	4.11e-06	591	73	9	15231748
Pubmed	Decreased myocardial nNOS, increased iNOS and abnormal ECGs in mouse models of Duchenne muscular dystrophy.	DMD UTRN	4.35e-06	2	73	2	10525423
Pubmed	Distribution of dystrophin- and utrophin-associated protein complexes during activation of human neutrophils.	DMD UTRN	4.35e-06	2	73	2	20434517
Pubmed	Plasma lipidomic analysis shows a disease progression signature in mdx mice.	DMD UTRN	4.35e-06	2	73	2	34155298
Pubmed	Far3 and five interacting proteins prevent premature recovery from pheromone arrest in the budding yeast Saccharomyces cerevisiae.	STRIP2 STRIP1	4.35e-06	2	73	2	12588993
Pubmed	In Vivo Genome Editing Restores Dystrophin Expression and Cardiac Function in Dystrophic Mice.	DMD UTRN	4.35e-06	2	73	2	28790199
Pubmed	Dystrophic changes in extraocular muscles after gamma irradiation in mdx:utrophin(+/-) mice.	DMD UTRN	4.35e-06	2	73	2	24466085
Pubmed	The Angiotensin Converting Enzyme Inhibitor Lisinopril Improves Muscle Histopathology but not Contractile Function in a Mouse Model of Duchenne Muscular Dystrophy.	DMD UTRN	4.35e-06	2	73	2	27110493
Pubmed	Rapid depletion of muscle progenitor cells in dystrophic mdx/utrophin-/- mice.	DMD UTRN	4.35e-06	2	73	2	24781208
Pubmed	Depletion of MOB1A/B causes intestinal epithelial degeneration by suppressing Wnt activity and activating BMP/TGF-β signaling.	MOB1B MOB1A	4.35e-06	2	73	2	30349003
Pubmed	Isolation and characterization of a genomic clone from the murine utrophin locus.	DMD UTRN	4.35e-06	2	73	2	8268660
Pubmed	Metabolic dysfunction and altered mitochondrial dynamics in the utrophin-dystrophin deficient mouse model of duchenne muscular dystrophy.	DMD UTRN	4.35e-06	2	73	2	25859846
Pubmed	Cancer susceptibility and embryonic lethality in Mob1a/1b double-mutant mice.	MOB1B MOB1A	4.35e-06	2	73	2	23143302
Pubmed	Membrane depolarization activates the mitochondrial protease OMA1 by stimulating self-cleavage.	OMA1 OPA1	4.35e-06	2	73	2	24719224
Pubmed	G-utrophin, the autosomal homologue of dystrophin Dp116, is expressed in sensory ganglia and brain.	DMD UTRN	4.35e-06	2	73	2	7731967
Pubmed	Characterization of neuromuscular synapse function abnormalities in multiple Duchenne muscular dystrophy mouse models.	DMD UTRN	4.35e-06	2	73	2	27037492
Pubmed	Role of dystrophin and utrophin for assembly and function of the dystrophin glycoprotein complex in non-muscle tissue.	DMD UTRN	4.35e-06	2	73	2	16710609
Pubmed	Improvement in survival and muscle function in an mdx/utrn(-/-) double mutant mouse using a human retinal dystrophin transgene.	DMD UTRN	4.35e-06	2	73	2	16487708
Pubmed	Nonclinical Exon Skipping Studies with 2'-O-Methyl Phosphorothioate Antisense Oligonucleotides in mdx and mdx-utrn-/- Mice Inspired by Clinical Trial Results.	DMD UTRN	4.35e-06	2	73	2	30672725
Pubmed	Voltage-gated ion channel dysfunction precedes cardiomyopathy development in the dystrophic heart.	DMD UTRN	4.35e-06	2	73	2	21677768
Pubmed	Talin, vinculin and DRP (utrophin) concentrations are increased at mdx myotendinous junctions following onset of necrosis.	DMD UTRN	4.35e-06	2	73	2	7962191
Pubmed	Consequences of the combined deficiency in dystrophin and utrophin on the mechanical properties and myosin composition of some limb and respiratory muscles of the mouse.	DMD UTRN	4.35e-06	2	73	2	9713852
Pubmed	Skeletal muscle fibrosis in the mdx/utrn+/- mouse validates its suitability as a murine model of Duchenne muscular dystrophy.	DMD UTRN	4.35e-06	2	73	2	25607927
Pubmed	Does utrophin expression in muscles of mdx mice during postnatal development functionally compensate for dystrophin deficiency?	DMD UTRN	4.35e-06	2	73	2	8021701
Pubmed	Correlation of Utrophin Levels with the Dystrophin Protein Complex and Muscle Fibre Regeneration in Duchenne and Becker Muscular Dystrophy Muscle Biopsies.	DMD UTRN	4.35e-06	2	73	2	26974331
Pubmed	Developmental studies of dystrophin-positive fibers in mdx, and DRP localization.	DMD UTRN	4.35e-06	2	73	2	8433092
Pubmed	Second-generation compound for the modulation of utrophin in the therapy of DMD.	DMD UTRN	4.35e-06	2	73	2	25935002
Pubmed	Utrophin deficiency worsens cardiac contractile dysfunction present in dystrophin-deficient mdx mice.	DMD UTRN	4.35e-06	2	73	2	16024571
Pubmed	Androgen receptor agonists increase lean mass, improve cardiopulmonary functions and extend survival in preclinical models of Duchenne muscular dystrophy.	DMD UTRN	4.35e-06	2	73	2	28453658
Pubmed	A quantitative study of bioenergetics in skeletal muscle lacking utrophin and dystrophin.	DMD UTRN	4.35e-06	2	73	2	11801396
Pubmed	Apo-dystrophin-1 and apo-dystrophin-2, products of the Duchenne muscular dystrophy locus: expression during mouse embryogenesis and in cultured cell lines.	DMD UTRN	4.35e-06	2	73	2	7987307
Pubmed	Utility of dystrophin and utrophin staining in childhood muscular dystrophy.	DMD UTRN	4.35e-06	2	73	2	16295426
Pubmed	Comparative analysis of the human dystrophin and utrophin gene structures.	DMD UTRN	4.35e-06	2	73	2	11861579
Pubmed	Distinct mechanical properties in homologous spectrin-like repeats of utrophin.	DMD UTRN	4.35e-06	2	73	2	30914715
Pubmed	Dystrophin is a microtubule-associated protein.	DMD UTRN	4.35e-06	2	73	2	19651889
Pubmed	Skeletal muscle-specific expression of a utrophin transgene rescues utrophin-dystrophin deficient mice.	DMD UTRN	4.35e-06	2	73	2	9590295
Pubmed	Comparison of skeletal muscle pathology and motor function of dystrophin and utrophin deficient mouse strains.	DMD UTRN	4.35e-06	2	73	2	22284942
Pubmed	Utrophin haploinsufficiency does not worsen the functional performance, resistance to eccentric contractions and force production of dystrophic mice.	DMD UTRN	4.35e-06	2	73	2	29879154
Pubmed	Haploinsufficiency of utrophin gene worsens skeletal muscle inflammation and fibrosis in mdx mice.	DMD UTRN	4.35e-06	2	73	2	17889902
Pubmed	Identification of Dp71 isoforms in the platelet membrane cytoskeleton. Potential role in thrombin-mediated platelet adhesion.	DMD UTRN	4.35e-06	2	73	2	12370193
Pubmed	Longitudinal metabolomic analysis of plasma enables modeling disease progression in Duchenne muscular dystrophy mouse models.	DMD UTRN	4.35e-06	2	73	2	32025735
Pubmed	OMA1 mediates OPA1 proteolysis and mitochondrial fragmentation in experimental models of ischemic kidney injury.	OMA1 OPA1	4.35e-06	2	73	2	24671334
Pubmed	Lifelong quercetin enrichment and cardioprotection in Mdx/Utrn+/- mice.	DMD UTRN	4.35e-06	2	73	2	27836895
Pubmed	Melatonin Rescues Influenza A Virus-Induced Cellular Energy Exhaustion via OMA1-OPA1-S in Acute Exacerbation of COPD.	OMA1 OPA1	4.35e-06	2	73	2	39039850
Pubmed	BGP-15 Improves Aspects of the Dystrophic Pathology in mdx and dko Mice with Differing Efficacies in Heart and Skeletal Muscle.	DMD UTRN	4.35e-06	2	73	2	27750047
Pubmed	Prevention of dystrophin-deficient cardiomyopathy in twenty-one-month-old carrier mice by mosaic dystrophin expression or complementary dystrophin/utrophin expression.	DMD UTRN	4.35e-06	2	73	2	17967782
Pubmed	Diaphragm rescue alone prevents heart dysfunction in dystrophic mice.	DMD UTRN	4.35e-06	2	73	2	21062902
Pubmed	Matricellular Protein CCN5 Gene Transfer Ameliorates Cardiac and Skeletal Dysfunction in mdx/utrn (±) Haploinsufficient Mice by Reducing Fibrosis and Upregulating Utrophin Expression.	DMD UTRN	4.35e-06	2	73	2	35557546
Pubmed	Characterization of the Ang/Tie2 Signaling Pathway in the Diaphragm Muscle of DMD Mice.	DMD UTRN	4.35e-06	2	73	2	37626761
Pubmed	Molecular heterogeneity of the dystrophin-associated protein complex in the mouse kidney nephron: differential alterations in the absence of utrophin and dystrophin.	DMD UTRN	4.35e-06	2	73	2	15565469
Pubmed	Loss of mitochondrial protease OMA1 alters processing of the GTPase OPA1 and causes obesity and defective thermogenesis in mice.	OMA1 OPA1	4.35e-06	2	73	2	22433842
Pubmed	The N- and C-Terminal Domains Differentially Contribute to the Structure and Function of Dystrophin and Utrophin Tandem Calponin-Homology Domains.	DMD UTRN	4.35e-06	2	73	2	26516677
Pubmed	Assessment of cardiac function in three mouse dystrophinopathies by magnetic resonance imaging.	DMD UTRN	4.35e-06	2	73	2	22209498
Pubmed	A Protocol for Simultaneous In Vivo Imaging of Cardiac and Neuroinflammation in Dystrophin-Deficient MDX Mice Using [18F]FEPPA PET.	DMD UTRN	4.35e-06	2	73	2	37108685
Pubmed	Prevention of the dystrophic phenotype in dystrophin/utrophin-deficient muscle following adenovirus-mediated transfer of a utrophin minigene.	DMD UTRN	4.35e-06	2	73	2	10694796
Pubmed	Dystrophin and dystrophin-related protein in the central nervous system of normal controls and Duchenne muscular dystrophy.	DMD UTRN	4.35e-06	2	73	2	8171962
Pubmed	Similar efficacy from specific and non-specific mineralocorticoid receptor antagonist treatment of muscular dystrophy mice.	DMD UTRN	4.35e-06	2	73	2	27822449
Pubmed	Micro-dystrophin gene therapy prevents heart failure in an improved Duchenne muscular dystrophy cardiomyopathy mouse model.	DMD UTRN	4.35e-06	2	73	2	33651713
Pubmed	Thermodynamic stability, unfolding kinetics, and aggregation of the N-terminal actin-binding domains of utrophin and dystrophin.	DMD UTRN	4.35e-06	2	73	2	22275054
Pubmed	NAD+ repletion improves muscle function in muscular dystrophy and counters global PARylation.	DMD UTRN	4.35e-06	2	73	2	27798264
Pubmed	Glycine administration attenuates progression of dystrophic pathology in prednisolone-treated dystrophin/utrophin null mice.	DMD UTRN	4.35e-06	2	73	2	31506484
Pubmed	Stress-induced OMA1 activation and autocatalytic turnover regulate OPA1-dependent mitochondrial dynamics.	OMA1 OPA1	4.35e-06	2	73	2	24550258
Pubmed	Skeletal and cardiac myopathies in mice lacking utrophin and dystrophin: a model for Duchenne muscular dystrophy.	DMD UTRN	4.35e-06	2	73	2	9288752
Pubmed	Utrophin-dystrophin-deficient mice as a model for Duchenne muscular dystrophy.	DMD UTRN	4.35e-06	2	73	2	9288751
Pubmed	Enhanced currents through L-type calcium channels in cardiomyocytes disturb the electrophysiology of the dystrophic heart.	DMD UTRN	4.35e-06	2	73	2	24337461
Pubmed	Combined gene therapy via VEGF and mini-dystrophin synergistically improves pathologies in temporalis muscle of dystrophin/utrophin double knockout mice.	DMD UTRN	4.35e-06	2	73	2	33987645
Pubmed	Activation of calcineurin and stress activated protein kinase/p38-mitogen activated protein kinase in hearts of utrophin-dystrophin knockout mice.	DMD UTRN	4.35e-06	2	73	2	11297940
Pubmed	Utrophin up-regulation by artificial transcription factors induces muscle rescue and impacts the neuromuscular junction in mdx mice.	DMD UTRN	4.35e-06	2	73	2	29408646
Pubmed	Bcat1 is controlled by Tsc2/mTORC1 pathway at expression levels and its deficiency together with Bcat2 inactivation suppresses the growth of a Tsc2-/- tumor cell line.	BCAT1 TSC2	4.35e-06	2	73	2	36965015
Pubmed	Rescue of severely affected dystrophin/utrophin-deficient mice through scAAV-U7snRNA-mediated exon skipping.	DMD UTRN	4.35e-06	2	73	2	22388933
Pubmed	Functional correction in mouse models of muscular dystrophy using exon-skipping tricyclo-DNA oligomers.	DMD UTRN	4.35e-06	2	73	2	25642938
Pubmed	Activation of non-myogenic mesenchymal stem cells during the disease progression in dystrophic dystrophin/utrophin knockout mice.	DMD UTRN	4.35e-06	2	73	2	25859011
Pubmed	Klotho gene silencing promotes pathology in the mdx mouse model of Duchenne muscular dystrophy.	KL DMD	4.35e-06	2	73	2	27154199
Pubmed	Satellite cells and utrophin are not directly correlated with the degree of skeletal muscle damage in mdx mice.	DMD UTRN	4.35e-06	2	73	2	15703201
Pubmed	Microtubule binding distinguishes dystrophin from utrophin.	DMD UTRN	4.35e-06	2	73	2	24706788
Pubmed	Utrophin suppresses low frequency oscillations and coupled gating of mechanosensitive ion channels in dystrophic skeletal muscle.	DMD UTRN	4.35e-06	2	73	2	25941878
Pubmed	Duchenne muscular dystrophy and the neuromuscular junction: the utrophin link.	DMD UTRN	4.35e-06	2	73	2	9297964
Pubmed	Dystrophin and utrophin do not play crucial roles in nonmuscle tissues in mice.	DMD UTRN	4.35e-06	2	73	2	10204788
Pubmed	SERCA1 overexpression minimizes skeletal muscle damage in dystrophic mouse models.	DMD UTRN	4.35e-06	2	73	2	25652448
Pubmed	Utrophin Compensates dystrophin Loss during Mouse Spermatogenesis.	DMD UTRN	4.35e-06	2	73	2	28785010
Pubmed	The role of proteases in excitation-contraction coupling failure in muscular dystrophy.	DMD UTRN	4.35e-06	2	73	2	25298424
Pubmed	Restoration of all dystrophin protein interactions by functional domains in trans does not rescue dystrophy.	DMD UTRN	4.35e-06	2	73	2	16307000
Pubmed	Expression of the dystrophin isoform Dp116 preserves functional muscle mass and extends lifespan without preventing dystrophy in severely dystrophic mice.	DMD UTRN	4.35e-06	2	73	2	21949353
Pubmed	Dystrophin and utrophin "double knockout" dystrophic mice exhibit a spectrum of degenerative musculoskeletal abnormalities.	DMD UTRN	4.35e-06	2	73	2	23097179
Pubmed	rAAV6-microdystrophin preserves muscle function and extends lifespan in severely dystrophic mice.	DMD UTRN	4.35e-06	2	73	2	16819550
Pubmed	The role of utrophin and Dp71 for assembly of different dystrophin-associated protein complexes (DPCs) in the choroid plexus and microvasculature of the brain.	DMD UTRN	4.35e-06	2	73	2	15501597
Pubmed	Enhanced expression of the alpha 7 beta 1 integrin reduces muscular dystrophy and restores viability in dystrophic mice.	DMD UTRN	4.35e-06	2	73	2	11257121
Pubmed	Characterization of dystrophin and utrophin diversity in the mouse.	DMD UTRN	4.35e-06	2	73	2	10072426
Pubmed	The sparing of extraocular muscle in dystrophinopathy is lost in mice lacking utrophin and dystrophin.	DMD UTRN	4.35e-06	2	73	2	9625743
Pubmed	Systemic human minidystrophin gene transfer improves functions and life span of dystrophin and dystrophin/utrophin-deficient mice.	DMD UTRN	4.35e-06	2	73	2	18973234
Pubmed	Human Mob1 proteins are required for cytokinesis by controlling microtubule stability.	MOB1B MOB1A	4.35e-06	2	73	2	22454515
Pubmed	Metabolic profiles of dystrophin and utrophin expression in mouse models of Duchenne muscular dystrophy.	DMD UTRN	4.35e-06	2	73	2	12387876
Pubmed	Renin-angiotensin-aldosterone system inhibitors improve membrane stability and change gene-expression profiles in dystrophic skeletal muscles.	DMD UTRN	4.35e-06	2	73	2	27881412
Pubmed	TORC2 signaling is antagonized by protein phosphatase 2A and the Far complex in Saccharomyces cerevisiae.	STRIP2 STRIP1	4.35e-06	2	73	2	22298706
Pubmed	Dystrophins, utrophins, and associated scaffolding complexes: role in mammalian brain and implications for therapeutic strategies.	DMD UTRN	4.35e-06	2	73	2	20625423
Pubmed	Utrophin influences mitochondrial pathology and oxidative stress in dystrophic muscle.	DMD UTRN	4.35e-06	2	73	2	29065908
Pubmed	Stabilization of the cardiac sarcolemma by sarcospan rescues DMD-associated cardiomyopathy.	DMD UTRN	4.35e-06	2	73	2	31039133
Cytoband	Ensembl 112 genes in cytogenetic band chr12p11	IPO8 CAPRIN2 ETFBKMT	3.47e-04	85	73	3	chr12p11
Cytoband	12p11.21	IPO8 ETFBKMT	5.64e-04	22	73	2	12p11.21
GeneFamily	EF-hand domain containing\|Spectrins	SPTBN5 SPTA1	1.96e-04	7	56	2	1113
GeneFamily	MOB kinase activators\|STRIPAK complex	MOB1B MOB1A	1.96e-04	7	56	2	647
GeneFamily	Helix-turn-helix CENPB type domain containing	TIGD2 JRKL	7.19e-04	13	56	2	533
GeneFamily	Zinc fingers ZZ-type\|Lysine acetyltransferases	DMD UTRN	1.40e-03	18	56	2	91
GeneFamily	Protein phosphatase catalytic subunits\|STRIPAK complex	STRIP2 STRIP1	1.73e-03	20	56	2	1371
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	OMA1 MYO3A MYO5B ARHGAP44 BCAT1 UTRN	6.23e-07	186	73	6	4e94158db52df41d71e67b02b9895a358eebee0f
ToppCell	Control-Epithelial_alveolar-AT_1-Differentiating_AT1\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	OMA1 MYO5B ARHGAP44 BCAT1 UTRN	1.08e-05	177	73	5	9af14a056eb6d88c6f11b09f6d4c0d3448d647d5
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MYO5B DOCK11 DNAI3 UTRN SDK1	1.20e-05	181	73	5	bd7e9437839bca543ca5945df43d6525e6a312a8
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	OMA1 MYO5B ARHGAP44 BCAT1 UTRN	1.37e-05	186	73	5	3aebe163799109ffc67e4e10ee47c2dd0886a92c
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK11 BCAT1 ARHGAP18 IL18R1 NLRP3	1.56e-05	191	73	5	468b5149d1533f03521844d3cce8633d44eb6ed4
ToppCell	(05)_Ciliated\|World / shred by cell type and Timepoint	C20orf96 CATIP ARHGAP18 DNAI3 CCDC65	1.80e-05	197	73	5	fee3cd16af8eea697cd64e8f64af505aaa2ac4b0
ToppCell	P07-Epithelial-airway_epithelial_cell-ciliated_cell_of_airway\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	AMER2 VILL DMD SDK1	1.17e-04	153	73	4	5501095bcf73080872ae01128f21399f9cfc5dd1
ToppCell	LPS_only-Epithelial_alveolar-AT_1-AT2_Progenitor\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	OMA1 MYO5B ARHGAP44 BCAT1	1.17e-04	153	73	4	e7a074ea8232bacf924be78a244a8507c7e1ebc8
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_PP_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MOB1B ETFBKMT SDK1 PADI1	1.20e-04	154	73	4	2d98bb7a784fc3215e0d4a1670d662e5df4716c3
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_PP_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MOB1B ETFBKMT SDK1 PADI1	1.20e-04	154	73	4	0dec222101530f1727184dbb7c03969d3884f111
ToppCell	10x5'-bone_marrow-Lymphocytic_Invariant-Inducer-like-ILC3\|bone_marrow / Manually curated celltypes from each tissue	KL ABCB5 CARD10 IL18R1	1.23e-04	155	73	4	83430a64c2cb5ad29caa3dacba76c28dd204ac40
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	C20orf96 CATIP DNAI3 CCDC65	1.35e-04	159	73	4	00a157d033627d0e65c3fbd38d652c4cf56b47f6
ToppCell	Severe-Lymphoid-NK-Proliferating_T\|Severe / Condition, Lineage, Cell class and cell subclass	ZNF530 HECW2 CERCAM HERC3	1.39e-04	160	73	4	cb2276d9bd78508644420e9580d3c17b914224cb
ToppCell	CV-Mild-4\|Mild / Virus stimulation, Condition and Cluster	BCAT1 HERC3 NLRP3 NBPF1	1.39e-04	160	73	4	2e24f8de5086b086863d3bf4d9afbd9bc93f4d5e
ToppCell	TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma\|TCGA-Brain / Sample_Type by Project: Shred V9	OMA1 MOB1B ANKRD27 NLRP3	1.45e-04	162	73	4	810881210e015c788814e4fe8d7a24c929cf2621
ToppCell	facs-Lung-Endomucin-3m-Myeloid-Myeloid_Dendritic_Type_2\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RNF123 ABCA13 CERCAM MCM5	1.60e-04	166	73	4	a2ce44702a0cd5fa5872cac3302d3c451205feef
ToppCell	facs-Lung-Endomucin-3m-Myeloid-myeloid_dendritic_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RNF123 ABCA13 CERCAM MCM5	1.60e-04	166	73	4	0f641302a6b71c4badaaf20f51162bfc2386b167
ToppCell	367C-Lymphocytic-NK_cells-NK_cell_E\|NK_cells / Donor, Lineage, Cell class and subclass (all cells)	ABCB5 DPY19L4 BCAT1 TSC2	1.63e-04	167	73	4	b5d15773be32cd277125fd3b4056a8fefaefa5ec
ToppCell	(08)_PNEC-(4)_1wkpi\|(08)_PNEC / shred by cell type and Timepoint	TSC2 ANKRD27	1.70e-04	12	73	2	f1b105bcdbe03be6765c820b42c752a24d502212
ToppCell	TCGA-Breast-Solid_Tissue_Normal-Breast_normal_tissue-Breast_normal_tissue-3\|TCGA-Breast / Sample_Type by Project: Shred V9	LVRN KL ABCB5 DMD	1.91e-04	174	73	4	7f8f5fafae08676d2b90cab9802c3c9320f1370e
ToppCell	TCGA-Breast-Solid_Tissue_Normal\|TCGA-Breast / Sample_Type by Project: Shred V9	LVRN KL ABCB5 DMD	1.91e-04	174	73	4	e2f240d60bffbe8e6d60f0bb405b231bd3c96875
ToppCell	PND07-28-samps-Epithelial-Epithelial-non_alveolar-Ciliated_cell_of_lung_parenchyma\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	C20orf96 CATIP DNAI3 CCDC65	1.91e-04	174	73	4	f41d05a3703d7092bd3c4a97c15ae13069aaa4ad
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-AT2_Progenitor\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	OMA1 MYO5B ARHGAP44 BCAT1	1.91e-04	174	73	4	d0e3d15731de6c19c232e3aa492c39d8151cf4ed
ToppCell	TCGA-Breast-Solid_Tissue_Normal-Breast_normal_tissue-Breast_normal_tissue\|TCGA-Breast / Sample_Type by Project: Shred V9	LVRN KL ABCB5 DMD	1.91e-04	174	73	4	0f3ec0d0d4344e10c9b48adc9174123f6402dc51
ToppCell	Basal_cells-Cryobiopsy_01\|World / lung cells shred on cell class, cell subclass, sample id	ABCA13 CBLC CARD10 SDK1	1.91e-04	174	73	4	a0060be3940043015dcc49a5157de5541aed24a1
ToppCell	TCGA-Breast-Solid_Tissue_Normal-Breast_normal_tissue\|TCGA-Breast / Sample_Type by Project: Shred V9	LVRN KL ABCB5 DMD	1.91e-04	174	73	4	1aadbf2642b6d1320ceabd92e6ff59e11f16c315
ToppCell	PND07-28-samps-Epithelial-Epithelial-non_alveolar\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	C20orf96 CATIP DNAI3 CCDC65	1.95e-04	175	73	4	c01a15b2084da4a18f8ff3623f44eb9dfe499f10
ToppCell	facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea-\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MYO5B CAPRIN2 JRKL STRIP1	1.95e-04	175	73	4	bb898796662b97f7459b7dda7cecf6a9bde8b055
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK11 ABCA13 CERCAM UTRN	2.00e-04	176	73	4	327a3e81b724252e36d786de92a3ffd721ea6d7b
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	C20orf96 CATIP CAPRIN2 DNAI3	2.04e-04	177	73	4	e8bb4f8ecd5e283efec966b9fc2040a6152d5551
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK11 ABCA13 CERCAM UTRN	2.04e-04	177	73	4	da8802a6351d3e510822f82e2fde8a4314a2216e
ToppCell	Control-Epithelial_alveolar-AT_1\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	OMA1 MYO5B ARHGAP44 BCAT1	2.08e-04	178	73	4	aa7d43c655df493f1330a5001efaa484e4a19f69
ToppCell	Control-Epithelial_alveolar-AT_1-AT1\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	OMA1 MYO5B ARHGAP44 BCAT1	2.08e-04	178	73	4	1817bc520f3d23da8c0fa09bba50ae703a820cb1
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-ependymal_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	C20orf96 CATIP CAPRIN2 DNAI3	2.08e-04	178	73	4	b1db59344c074c7c80169fc2c5cd5fc89f3fe463
ToppCell	PND28-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYO5B WWP1 ARHGAP44 IL18R1	2.08e-04	178	73	4	a3af5d9c55858e36be0498081029ecb0acaeb3d3
ToppCell	PND28-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYO5B WWP1 ARHGAP44 IL18R1	2.08e-04	178	73	4	b3b88989bd602cfb55bb5c47731deb99288a8952
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-Ependyma\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	C20orf96 CATIP CAPRIN2 DNAI3	2.08e-04	178	73	4	579cdc14f28b459e200ae2102e0bd4df8a2c0dcb
ToppCell	TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Mucinous_Colon_Adenocarcinoma-10\|TCGA-Colorectal / Sample_Type by Project: Shred V9	HECW2 BCAT1 SDK1 NLRP3	2.13e-04	179	73	4	cc079ba015326dccde955c5eafa3e4a2e40de192
ToppCell	LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	OMA1 MYO5B ARHGAP44 BCAT1	2.13e-04	179	73	4	fd2cbee532e7b44113410dca82aec7db1a7fb69f
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	OMA1 MYO5B ARHGAP44 BCAT1	2.13e-04	179	73	4	04ce3673e46606f63d9c87bcba3a64c96817d812
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-5_VIP_TOX2\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DOCK11 ARHGAP18 IL18R1 SDK1	2.22e-04	181	73	4	35bcdcd2651149692e5b150e887c0f450c81d2d4
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYO5B ARHGAP44 BCAT1 UTRN	2.22e-04	181	73	4	b45b11428d13950369347e051d4d517efb2bd4fd
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK11 ABCA13 CERCAM UTRN	2.22e-04	181	73	4	071f9bb5d39070cdc473d9b0e094d196bc702b56
ToppCell	PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYO5B ABCA13 WWP1 IL18R1	2.27e-04	182	73	4	573771130247e869e4e58f22d4a1cb31989635cf
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_1-AT1-AT2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	OMA1 MYO5B ARHGAP44 BCAT1	2.27e-04	182	73	4	cc79e0cc21e2fdc4ef77f052818d27b9f707aec1
ToppCell	wk_15-18-Epithelial-Proximal_epithelial-Deuterosomal\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	CATIP MYO5B DNAI3 CCDC65	2.27e-04	182	73	4	000eca5baa6eb2335a1e6d76a13fff5382b0e150
ToppCell	PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYO5B ABCA13 WWP1 IL18R1	2.27e-04	182	73	4	6cfaa2b3b3974c13b01c943f4adb70768dcc35e4
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Myeloid\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	BCAT1 ARHGAP18 IL18R1 NLRP3	2.32e-04	183	73	4	a97f052950429245c3231464271e1ba539863bba
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-AT1\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	OMA1 MYO5B ARHGAP44 BCAT1	2.32e-04	183	73	4	274483009b309289e4cb84beedf6806430db6ff6
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-AT1-AT2\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	OMA1 MYO5B ARHGAP44 BCAT1	2.32e-04	183	73	4	06ac66726ec53db810ebb90ec69cfdb903da53f6
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_1\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	OMA1 MYO5B ARHGAP44 BCAT1	2.32e-04	183	73	4	ff6dde877659cde9daa3263db0932c9c9ef1adac
ToppCell	LPS_only-Epithelial_alveolar-AT_2\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	OMA1 MYO5B ARHGAP44 BCAT1	2.32e-04	183	73	4	e972432dd4d1bd31bb0982f4df3061e5e152658f
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA13 SPTA1 DMD SDK1	2.36e-04	184	73	4	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYO5B ARHGAP44 BCAT1 UTRN	2.36e-04	184	73	4	42ce855b4f8475a8298192feec785bdc69bc5bb0
ToppCell	facs-Lung-EPCAM-24m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	C20orf96 CATIP DNAI3 CCDC65	2.36e-04	184	73	4	afb11ab301ef9801333dbb53ccff4bd0d44f1677
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_1-AT2_Progenitor\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	OMA1 MYO5B ARHGAP44 BCAT1	2.36e-04	184	73	4	7cc5796557379c3d1db078c1aeda40659c6e401c
ToppCell	facs-Lung-EPCAM-24m-Epithelial-Ciliated_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	C20orf96 CATIP DNAI3 CCDC65	2.36e-04	184	73	4	a411c0bcb283534a1c15f22473c46b7d87e01294
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA13 SPTA1 DMD SDK1	2.36e-04	184	73	4	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_1\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	OMA1 MYO5B ARHGAP44 BCAT1	2.36e-04	184	73	4	cdf6f1c6cce97a7effa0c55959652e2c0b6992b3
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA13 SPTA1 DMD SDK1	2.36e-04	184	73	4	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	Control-Epithelial_cells-Airway_goblet\|Control / group, cell type (main and fine annotations)	VILL ABCA13 CBLC PADI1	2.36e-04	184	73	4	d92a71441e4e19f8c301999d8186f8e48e3cd162
ToppCell	droplet-Lung-18m-Hematologic-myeloid-classical_monocyte_proliferating-classical_monocyte_proliferating_l33-52\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ABCA13 CAPRIN2 CERCAM MCM5	2.41e-04	185	73	4	47c69500877b851c0c9744f5e1ef2ee0bff99168
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_1-AT1-AT2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	OMA1 MYO5B ARHGAP44 BCAT1	2.41e-04	185	73	4	3bef59cc0aa939d2a7e52f0f6c61bc00528fe50b
ToppCell	LPS_only-Epithelial_alveolar-AT_1-AT1-AT2\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	OMA1 MYO5B ARHGAP44 BCAT1	2.41e-04	185	73	4	68f428e169cfb77de970bdfdeea9b9f16f68d2ba
ToppCell	LPS_only-Epithelial_alveolar-AT_1-AT1\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	OMA1 MYO5B ARHGAP44 BCAT1	2.41e-04	185	73	4	0c247a3f394c42e2a6f67fee3d9cf33096fecd13
ToppCell	Control-Epithelial_alveolar\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	OMA1 MYO5B ARHGAP44 BCAT1	2.41e-04	185	73	4	3937e026add96a396122139daf8011cfbc60e75c
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	OMA1 MYO5B ARHGAP44 BCAT1	2.41e-04	185	73	4	c82eab551f65ecebe6db908eda9f9eb3414693c7
ToppCell	droplet-Bladder-BLADDER-1m-Hematologic-nan\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DOCK11 BEND3 MCM5 IL18R1	2.41e-04	185	73	4	969248b63d4ce335f223528de756bcddffadbd77
ToppCell	(6)_Macrophage-(60)_Macrophage\|(6)_Macrophage / shred on Cell_type and subtype	MMP14 UTRN NLRP3	2.45e-04	74	73	3	356978d2ee61e7042d7a9ad3bc744d3e7a7f76c0
ToppCell	LPS_only-Epithelial_alveolar\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	OMA1 MYO5B ARHGAP44 BCAT1	2.46e-04	186	73	4	e0a2ea4b46af742bc7c9b2072bb85e27d5c92712
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MYO3A MYO5B DOCK11 SDK1	2.46e-04	186	73	4	f28d72b47624b69a580b4429e2be560a26898591
ToppCell	facs-Lung-EPCAM-3m\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO5B ARHGAP44 CBLC IL18R1	2.46e-04	186	73	4	7c4eb769574f9f32753cea1cc38c711dabba88b9
ToppCell	18-Distal-Epithelial-Multiciliated_precursor\|Distal / Age, Tissue, Lineage and Cell class	CATIP MYO5B DNAI3 CCDC65	2.46e-04	186	73	4	58ab1360a1730655a5939295ba05997ac4a2d14e
ToppCell	PND14-Epithelial-Epithelial_Airway\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	C20orf96 CATIP DNAI3 CCDC65	2.51e-04	187	73	4	1399c703505211c510b3f14c7a2aa9930566c473
ToppCell	LPS-antiTNF-Epithelial_alveolar\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	OMA1 MYO5B ARHGAP44 BCAT1	2.51e-04	187	73	4	201ff693e4756ee3e44762885b3a303a77eb535b
ToppCell	droplet-Lung-3m-Epithelial-airway_epithelial-lung_ciliated_cell-ciliated_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	C20orf96 CATIP DNAI3 CCDC65	2.51e-04	187	73	4	1bba994aaaa9825b54aaeaff3829850267bc4602
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYO5B ARHGAP44 BCAT1 UTRN	2.51e-04	187	73	4	58d48128547ee3513d0bf7f78e61b76b1c472ca9
ToppCell	LPS_only-Epithelial_alveolar-AT_1\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	OMA1 MYO5B ARHGAP44 BCAT1	2.51e-04	187	73	4	ff26a533d310126521efe1d05cf8b9d32e524550
ToppCell	droplet-Lung-3m-Epithelial-airway_epithelial-lung_ciliated_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	C20orf96 CATIP DNAI3 CCDC65	2.51e-04	187	73	4	d6ac351e7aeba98851d308c14ac395044fe4fbbb
ToppCell	LPS-IL1RA-Epithelial_alveolar\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	OMA1 MYO5B ARHGAP44 BCAT1	2.57e-04	188	73	4	6164d467b612767ceba15de34176bcc8e8c36ab8
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	OMA1 MYO5B ARHGAP44 BCAT1	2.57e-04	188	73	4	43a0508d2524a5b310e89e9422843dcaab999bc3
ToppCell	Ciliated\|World / Class top	C20orf96 CATIP DNAI3 CCDC65	2.57e-04	188	73	4	cc9178361360b5800f96516ed6a65089c144b1ce
ToppCell	PND10-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	C20orf96 CATIP DNAI3 CCDC65	2.62e-04	189	73	4	02c6128a9ab5818e0881dcadafdad5f08b9a67cf
ToppCell	PND10-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	C20orf96 CATIP DNAI3 CCDC65	2.62e-04	189	73	4	164ea92ff6a1aa2ead1c9b8f64f99a9d65437232
ToppCell	facs-Lung-24m-Epithelial-airway_epithelial-lung_ciliated_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	C20orf96 CATIP DNAI3 CCDC65	2.62e-04	189	73	4	1c28ad1263891d963e483b6847d8e89cc1b2d07e
ToppCell	droplet-Lung-3m-Epithelial-airway_epithelial\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	C20orf96 CATIP DNAI3 CCDC65	2.62e-04	189	73	4	a28e0922e10013ae79266f6a3f9305e6ee614d8b
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_1-AT2_Progenitor\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	OMA1 MYO5B ARHGAP44 BCAT1	2.62e-04	189	73	4	5f883ef4cc0383142d538ae61f4fb40dfdb8ef18
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MYO3A MYO5B DOCK11 SDK1	2.62e-04	189	73	4	3b48b0d220cc24d5170713d61fa91f5bb6c21841
ToppCell	facs-Lung-24m-Epithelial-airway_epithelial-lung_ciliated_cell-ciliated_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	C20orf96 CATIP DNAI3 CCDC65	2.62e-04	189	73	4	00b20c2ed7876486c8e42e3a5b13023f44987a34
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	BCAT1 ARHGAP18 IL18R1 NLRP3	2.62e-04	189	73	4	7ccea2df93bb4b37417bbc8f6c85a61ece95211a
ToppCell	PND10-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	C20orf96 CATIP DNAI3 CCDC65	2.62e-04	189	73	4	a85099bd598a27ee64ee0664d051d89fa8d62fc9
ToppCell	Ciliated\|World / shred by cell class for parenchyma	CATIP LGALS13 DNAI3 CCDC65	2.62e-04	189	73	4	711181ca3b9102fb155168b646b0a9b09ff215b2
ToppCell	Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)\|Children_(3_yrs) / Lineage, Cell type, age group and donor	WWP1 BCAT1 ARHGAP18 NLRP3	2.67e-04	190	73	4	f573fef3762a30c38cf8fa7f45df0ffbb49dc873
ToppCell	367C-Lymphocytic-NK_cells-NK_cell_B1\|NK_cells / Donor, Lineage, Cell class and subclass (all cells)	OMA1 RNF123 IPO8 CERCAM	2.67e-04	190	73	4	2434b8ad2976eab7d9147012c28454ab29670709
ToppCell	PND14-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	C20orf96 CATIP DNAI3 CCDC65	2.67e-04	190	73	4	088e3f39a1e5e11354d6e7458e8e6a39f14936b3
ToppCell	PND14-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	C20orf96 CATIP DNAI3 CCDC65	2.67e-04	190	73	4	35248a8be476ea8d06d67c3d98a25be1f7c150b7
ToppCell	PND14-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	C20orf96 CATIP DNAI3 CCDC65	2.67e-04	190	73	4	5f5206f9e725070d865f4c891ff08bb750e58582
ToppCell	PND03-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	C20orf96 CATIP DNAI3 CCDC65	2.72e-04	191	73	4	bda8faf92495c8b362850c0aff4fc6fbdd9c563b
ToppCell	PND03-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	C20orf96 CATIP DNAI3 CCDC65	2.72e-04	191	73	4	6880fb348bb0915db9a5da4f3566ca9ff93ed258
ToppCell	PND03-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	C20orf96 CATIP DNAI3 CCDC65	2.78e-04	192	73	4	b5cdc2dae3154b1e4ade88f841f38584402ffe33
Disease	Duchenne muscular dystrophy (implicated_via_orthology)	CAPN2 DMD UTRN	9.00e-05	36	71	3	DOID:11723 (implicated_via_orthology)
Disease	basal cell adhesion molecule measurement	ARHGAP44 CBLC	1.58e-04	8	71	2	EFO_0008032
Disease	Cannabis use	IPO8 SDK1	6.70e-04	16	71	2	EFO_0007585
Disease	sphingosine 1-phosphate measurement	OMA1 DMD	8.52e-04	18	71	2	EFO_0800185
Disease	muscular dystrophy (implicated_via_orthology)	DMD UTRN	1.16e-03	21	71	2	DOID:9884 (implicated_via_orthology)
Disease	Colorectal Carcinoma	OMA1 AMER2 KL ABCA13 ABCB5 MCM3AP DMD	1.49e-03	702	71	7	C0009402
Disease	airway responsiveness measurement	IPO8 CAPRIN2	1.52e-03	24	71	2	EFO_0006897
Disease	multisite chronic pain	RNF123 UTRN SDK1	1.58e-03	95	71	3	EFO_0010100
Disease	indole-3-propionate measurement	EIF4G2 DDX1	1.93e-03	27	71	2	EFO_0010501
Disease	chronic kidney disease (biomarker_via_orthology)	KL OPA1	2.07e-03	28	71	2	DOID:784 (biomarker_via_orthology)
Disease	survival time, coronary artery disease	BRMS1L KLHL22	2.38e-03	30	71	2	EFO_0000714, EFO_0001645

Protein segments in the cluster

Peptide	Gene	Start	Entry
VDDTYLQEFWDMLSQ	AMER2	431	Q8N7J2
LQWAEELRDQYLQEM	CARD10	346	Q9BWT7
MNLFLYWINEDGEEE	BCAT1	261	P54687
EQLQLYWAMDSTFEL	CBLC	336	Q9ULV8
MLYQDIAWFDEKENS	ABCB5	776	Q2M3G0
EYESKLEFQSMWNDL	CCDC65	186	Q8IXS2
IPEEYLDWQELEMQL	ABCA13	571	Q86UQ4
EEDDDLEYLWETAQM	AMER1	401	Q5JTC6
WEELFLMKVNLEYLE	ARMH3	46	Q5T2E6
EWMTQAEEEYLERDF	DMD	1171	P11532
VDDVWFALDTEYMVL	LVRN	176	Q6Q4G3
IMNTFIDDWKYLAEE	DNAI3	296	Q8IWG1
YQWMDTENFVLPDDD	MMP14	261	P50281
FDSELELMTYINENW	MTF2	286	Q9Y483
NDRWIQDEMEFGYIE	PADI1	346	Q9ULC6
EIYFPDMQEEEAWLQ	BEND3	456	Q5T5X7
DLEMVRYLLEWTEED	ANKRD27	681	Q96NW4
LEYLDEEFHQSLQWM	HECW2	1346	Q9P2P5
YEEALLQKMWESQDF	C20orf96	281	Q9NUD7
LNEEDVIYWMFGEEN	IL18R1	241	Q13478
EEEIWEELSVMEVYD	MAGEA1	211	P43355
REEEIWEFLNMLGIY	MAGEB4	216	O15481
GEYWIEVEMEDLASF	MCM5	66	P33992
EISNLVDIQEDYLMW	HERC3	616	Q15034
SEDMAEEDVYWLSAL	MCM3AP	1466	O60318
TLEEIYSWIDNFVME	CPA5	141	Q8WXQ8
IWYNEMQLLSEIEEH	DDX1	651	Q92499
YEELDRAMLEWFNQQ	JRKL	76	Q9Y4A0
DYLMTWVQDQLDDET	MOB1B	116	Q7L9L4
YDMEIIEEEAFLAWK	EIF4G2	856	P78344
WALDMDEIEKYQEVE	NBPF1	941	Q3BBV0
LNEVMENIEVYHEFW	THAP12	521	O43422
IWMLEETTDYVPFED	LGALS13	71	Q9UHV8
SDKQQWDAAIYFMEE	OPA1	736	O60313
DFLMSWVDEENILDV	KLHL22	141	Q53GT1
YLAAETEQEMEEWLI	DOCK11	251	Q5JSL3
MDESVLKFYTQQWED	CUL1	111	Q13616
LQEFYDPDTVELMTW	DPY19L4	556	Q7Z388
LVWEEDMELYSKFLD	CATIP	291	Q7Z7H3
VEDQMEQSSLYFWDL	CAPRIN2	271	Q6IMN6
DYLEVQEMTDITWLN	KL	826	Q9UEF7
IVYMLQDLDILEDWT	BRMS1L	211	Q5PSV4
WDLVVLGDMFYDEDL	ETFBKMT	181	Q8IXQ9
MEDVEAEKLSWDLIY	CERCAM	431	Q5T4B2
FWMNPQYLIKLEEED	CAPN2	381	P17655
EFTIEELEEWMEYEL	SDK1	1236	Q7Z5N4
ELEEWMEYELQMQAF	SDK1	1241	Q7Z5N4
FSVMCYKDEDEELWQ	IPO8	356	O15397
DSIEEEWMGLLEYLS	NLRP3	111	Q96P20
EEYWDLQDMLTNRQD	RTL1	631	A6NKG5
EMQEWMTQAEEEYLE	UTRN	1136	P46939
EYSEENMLFWLACEE	RGS19	111	P49795
EWLELEEDAQKAYIM	STRIP2	96	Q9ULQ0
DYLMTWVQDQLDDET	MOB1A	116	Q9H8S9
EDFQMNYDLWLEREV	STRIP1	811	Q5VSL9
ILEFLEEWSMENLEE	POLR2B	541	P30876
EPLMTFELYDEWIQA	ARHGAP44	336	Q17R89
LDTDIFNEWMNEEDY	SMARCC1	271	Q92922
LSELEYEAWMEEFKN	OMA1	236	Q96E52
LQEELAIYWSSMEEL	SPTBN5	1671	Q9NRC6
YEELDRVMIEWFNQQ	TIGD2	76	Q4W5G0
VLDLLWLFMEDYEVQ	RNF123	361	Q5XPI4
WLFMEDYEVQDCLKQ	RNF123	366	Q5XPI4
MEDVNDWLTELYGDQ	UBE4B	731	O95155
DIYWSEEMEDRLQAL	RNH1	436	P13489
YRDLEELEEWISEML	SPTA1	1506	P02549
YLQFMQNAEEEEAWI	SPTA1	1821	P02549
SQDSLDELSMEDYWI	ARHGAP18	66	Q8N392
DELSMEDYWIELENI	ARHGAP18	71	Q8N392
DLDKYDIMLLDTWQE	VILL	636	O15195
IYFSQEEWELLDEMQ	ZNF530	21	Q6P9A1
LQWLQYFDEKELEVM	WWP1	786	Q9H0M0
SGLEDALWNMYVEEE	USP40	196	Q9NVE5
ALWNMYVEEEVFDCD	USP40	201	Q9NVE5
DIYETELSQWVNMEE	ZNF461	116	Q8TAF7
LEEELADFVLQWMDV	TSC2	156	P49815
VIEYEDNWPLLDMFL	MYO3A	766	Q8NEV4
EEYMKEQIPWTLIDF	MYO5B	476	Q9ULV0